Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Pharmaceutical: Value at Last - WSJ
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva, Allergan reach $107 million deal with Rhode Island over opioid crisis
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
The Adderall supply squeeze in the US is growing
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Intas To Buy Teva's UK, Ireland Assets For 603 Million Pounds
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva's New CEO to Cut 25% of Jobs to Rescue Ailing Drugmaker | Fortune
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva makes $40.1 billion takeover bid for Mylan | Mint
U.S. charges Teva in generic drugs price-fixing probe
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
